176 related articles for article (PubMed ID: 26389777)
1. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
Goswami T; Audett J
Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
[TBL] [Abstract][Full Text] [Related]
2. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
Lobo S; Sachdeva S; Goswami T
Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
[TBL] [Abstract][Full Text] [Related]
3. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
[TBL] [Abstract][Full Text] [Related]
4. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
[TBL] [Abstract][Full Text] [Related]
5. Transdermal drug delivery system: patent reviews.
Samad A; Ullah Z; Alam MI; Wais M; Shams MS
Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):143-52. PubMed ID: 19519574
[TBL] [Abstract][Full Text] [Related]
6. Practical considerations for optimal transdermal drug delivery.
Durand C; Alhammad A; Willett KC
Am J Health Syst Pharm; 2012 Jan; 69(2):116-24. PubMed ID: 22215357
[TBL] [Abstract][Full Text] [Related]
7. Passive transdermal systems whitepaper incorporating current chemistry, manufacturing and controls (CMC) development principles.
Van Buskirk GA; Arsulowicz D; Basu P; Block L; Cai B; Cleary GW; Ghosh T; González MA; Kanios D; Marques M; Noonan PK; Ocheltree T; Schwarz P; Shah V; Spencer TS; Tavares L; Ulman K; Uppoor R; Yeoh T
AAPS PharmSciTech; 2012 Mar; 13(1):218-30. PubMed ID: 22215291
[TBL] [Abstract][Full Text] [Related]
8. Critical attributes of transdermal drug delivery system (TDDS)--a generic product development review.
Ruby PK; Pathak SM; Aggarwal D
Drug Dev Ind Pharm; 2014 Nov; 40(11):1421-8. PubMed ID: 24467407
[TBL] [Abstract][Full Text] [Related]
9. Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana™ methylphenidate transdermal system.
Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
Drug Dev Ind Pharm; 2011 Oct; 37(10):1217-24. PubMed ID: 21438703
[TBL] [Abstract][Full Text] [Related]
10. The transdermal revolution.
Thomas BJ; Finnin BC
Drug Discov Today; 2004 Aug; 9(16):697-703. PubMed ID: 15341783
[TBL] [Abstract][Full Text] [Related]
11. Stereomicroscopic imaging technique for the quantification of cold flow in drug-in-adhesive type of transdermal drug delivery systems.
Krishnaiah YS; Katragadda U; Khan MA
J Pharm Sci; 2014 May; 103(5):1433-42. PubMed ID: 24585397
[TBL] [Abstract][Full Text] [Related]
12. Transdermal delivery systems.
Merkle HP
Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):135-53. PubMed ID: 2657273
[TBL] [Abstract][Full Text] [Related]
13. Transdermal drug delivery systems for fighting common viral infectious diseases.
Wang FY; Chen Y; Huang YY; Cheng CM
Drug Deliv Transl Res; 2021 Aug; 11(4):1498-1508. PubMed ID: 34024014
[TBL] [Abstract][Full Text] [Related]
14. Unique structure and property of cyclodextrins and their application in transdermal drug delivery.
Hu J; Tao Z; Cao S
Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):449-56. PubMed ID: 19907720
[TBL] [Abstract][Full Text] [Related]
15. Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
Agrawal SS; Aggarwal A
Contemp Clin Trials; 2010 Jul; 31(4):272-8. PubMed ID: 20382272
[TBL] [Abstract][Full Text] [Related]
16. Release liner removal method for transdermal drug delivery systems (TDDS).
Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
J Pharm Sci; 2010 Jul; 99(7):3177-87. PubMed ID: 20135693
[TBL] [Abstract][Full Text] [Related]
17. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.
Ham AS; Buckheit RW
Ther Deliv; 2015 Feb; 6(2):217-29. PubMed ID: 25690088
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
[TBL] [Abstract][Full Text] [Related]
19. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.
Shi Y; Li Y; Wu J; Wang W; Dong A; Zhang J
J Biomater Sci Polym Ed; 2014; 25(7):713-28. PubMed ID: 24641249
[TBL] [Abstract][Full Text] [Related]
20. Taro corms mucilage/HPMC based transdermal patch: an efficient device for delivery of diltiazem hydrochloride.
Sarkar G; Saha NR; Roy I; Bhattacharyya A; Bose M; Mishra R; Rana D; Bhattacharjee D; Chattopadhyay D
Int J Biol Macromol; 2014 May; 66():158-65. PubMed ID: 24556117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
